Effects of early enteral nutrition on immune function of severe acute pancreatitis patients

Jia-Kui Sun, Xin-Wei Mu, Wei-Qin Li, Zhi-Hui Tong, Jing Li, Shu-Yun Zheng, Jia-Kui Sun, Xin-Wei Mu, Wei-Qin Li, Zhi-Hui Tong, Jing Li, Shu-Yun Zheng

Abstract

Aim: To investigate the effects of early enteral nutrition (EEN) on the immune function and clinical outcome of patients with severe acute pancreatitis (SAP).

Methods: Patients were randomly allocated to receive EEN or delayed enteral nutrition (DEN). Enteral nutrition was started within 48 h after admission in EEN group, whereas from the 8(th) day in DEN group. All the immunologic parameters and C-reactive protein (CRP) levels were collected on days 1, 3, 7 and 14 after admission. The clinical outcome variables were also recorded.

Results: Sixty SAP patients were enrolled to this study. The CD4+ T-lymphocyte percentage, CD4+/CD8+ ratio, and the CRP levels in EEN group became significantly lower than in DEN group from the 7(th) day after admission. In contrast, the immunoglobulin G (IgG) levels and human leukocyte antigen-DR expression in EEN group became significantly higher than in DEN group from the 7(th) day after admission. No difference of CD8+ T-lymphocyte percentage, IgM and IgA levels was found between the two groups. The incidences of multiple organ dysfunction syndrome, systemic inflammatory response syndrome, and pancreatic infection as well as the duration of intensive care unit stay were significantly lower in EEN group than in DEN group. However, there was no difference of hospital mortality between the two groups.

Conclusion: EEN moderates the excessive immune response during the early stage of SAP without leading to subsequent immunosuppression. EEN can improve the clinical outcome, but not decrease the hospital mortality of SAP patients.

Trial registration: ClinicalTrials.gov NCT01507766.

Keywords: Early enteral nutrition; Immune; Severe acute pancreatitis.

Figures

Figure 1
Figure 1
Comparisons of T-lymphocyte subsets percentage between early enteral nutrition and delayed enteral nutrition groups. Results are expressed as median (interquartile range). A: Comparison of CD4+ T-lymphocyte percentage between early enteral nutrition (EEN) and delayed enteral nutrition (DEN) groups; B: Comparison of CD8+ T-lymphocyte percentage between EEN and DEN groups; C: Comparison of CD4+/CD8+ ratio between EEN and DEN groups. aP < 0.05, EEN groups vs DEN groups.
Figure 2
Figure 2
Comparisons of immunoglobulin subtypes between early enteral nutrition and delayed enteral nutrition groups. Results are expressed as median (interquartile range). A: Comparison of immunoglobulin G (IgG) levels between early enteral nutrition (EEN) and delayed enteral nutrition (DEN) groups; B: Comparison of IgM levels between EEN and DEN groups; C: Comparison of IgA levels between EEN and DEN groups. aP < 0.05, EEN groups vs DEN groups.
Figure 3
Figure 3
Comparisons of human leukocyte antigen-DR expression and C-reactive protein levels between early enteral nutrition and delayed enteral nutrition groups. Results are expressed as median (interquartile range). A: Comparison of human leukocyte antigen-DR (HLA-DR) expression between early enteral nutrition (EEN) and delayed enteral nutrition (DEN) groups; B: Comparison of C-reactive protein (CRP) levels between EEN and DEN groups. aP < 0.05, EEN groups vs DEN groups.

Source: PubMed

3
Prenumerera